Browsing Category
Pharma Industry News
4757 posts
Business-News-Today.com section for global pharma industry news, Indian pharma sector latest news, pharma sector news today, pharmaceuticals industry news.
Accenture invests in Turbine to advance AI-powered drug discovery
Accenture (NYSE: ACN) has announced a strategic investment through Accenture Ventures into Turbine, a pioneering predictive simulation company.…
FDA grants accelerated approval to Bristol Myers Squibb’s Breyanzi for follicular lymphoma
Bristol Myers Squibb (NYSE: BMY) has announced a significant breakthrough in the treatment of follicular lymphoma with the…
Mankind Pharma India records 62% surge in Q4 FY24 PAT at Rs 477cr
Mankind Pharma India, the nation’s fourth-largest pharmaceutical company, announced robust financial results for the fourth quarter and the…
Eisai initiates rolling submission for Leqembi autoinjector BLA to FDA
BioArctic AB’s partner Eisai has initiated the rolling submission of a Biologics License Application (BLA) to the U.S.…
Brii Biosciences receives breakthrough therapy designations for HBV treatments
Brii Biosciences Limited, a biotechnology company developing therapies for diseases with high unmet need, announced that the Center…
Kodiak Sciences advances Phase 3 study of tarcocimab tedromer in diabetic retinopathy
Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company focused on developing transformative therapeutics for retinal diseases, announced that…
Sanjivani Paranteral reports 58% growth in Q4 FY24 revenue at Rs 128.64 million
Sanjivani Paranteral Ltd (BSE: 531569), a renowned pharmaceutical company based in Mumbai with manufacturing facilities in Navi Mumbai…
Be Biopharma unveils promising preclinical results for hypophosphatasia treatment using engineered B cell medicines
Be Biopharma, Inc. has presented groundbreaking preclinical findings that underscore the potential of Engineered B Cell Medicines (BCMs)…
Setback for Bristol Myers Squibb: CheckMate -73L trial fails to meet endpoint
Bristol Myers Squibb (NYSE: BMY) announced that its Phase 3 CheckMate -73L trial did not achieve its primary…
Cardurion Pharmaceuticals reveals breakthrough results in heart failure treatment with PDE9 inhibitor
In a significant development for cardiovascular disease treatment, Cardurion Pharmaceuticals, Inc., a clinical-stage biotechnology company, has presented positive…